Search

What an EHA Innovation Grant supports

Our EHA Innovation Grant supports high-quality clinical or translational research in hematology. To reflect the collaborative spirit of the grant, no more than 40% of the total grant should be allocated to one member of the consortium.

Read more

Abstract Presentation Information

Thank you for submitting your abstract to the EHA Research Conference 2025, to be held on March 17-20, 2025 in Málaga, Spain.

Read more

Meeting Program

EHA-SWG Secondary AML - April 2025



Read more

Meeting Program

Program by dayPlease click on the image to open the full program by day. Program-at-a-glance

Please click on the image to open the program-at-a-glance.

Read more

Program-at-a-glance

To access a PDF of the program at a glance, select the image or the button below. You may find more details in the preliminary program per day.  

Read the program PDF

Read more

Deadlines & Announcements

New announcements will be published as soon as new elements for the Congress Sponsor Program for EHA2025 are released.

Read more

Register for EHA2025

Get ready to make new connections in Milan from June 12–15, 2025. Register now for EHA's reimagined Congress experience.

Read more

FDA Reports of Secondary Malignancies Following Chimeric Antigen Receptor (CAR) T Cell Therapies and Relative Risk: an EBMT-EHA-GoCART Coalition Statement

We need to bring your attention to the recent warning disseminated by the Food and Drug Administration (FDA) regarding T-cell lymphomas in patients undergoing Chimeric Antigen Receptor T-cell (CAR-T) therapy (1).

Read more